JZ1.40

Our research focuses on the development of new drugs for the treatment of colon cancer, metabolic and neurodegenerative diseases.

VIEW FEATURES

JZ1.40

Therapeutic area

Neurodegenerative

Target disease

Cognitive enhancement

Study phase

Preclinical: In vitro

100%

Preclinical: In vivo

100%

Clinic I

0

Clinic II

Not initiated

Clinic III

Not initiated

Patent No.

Application No. ES201830841

Discover the Future

We are a biotechnology company committed to the discovery of efficient and effective bioactive principles as pharmaceuticals, nutraceuticals or useful in the field of plant biology.